We are live on ! Find out more
CCC

Chelsea Counsel Company Portfolio holdings

AUM $225M
1-Year Est. Return 45.99%
This Fund
S&P 500
This Quarter Est. Return
+6.18%
1 Year Est. Return
+45.99%
3 Year Est. Return
+94.6%
5 Year Est. Return
+122.61%
10 Year Est. Return
+380.48%
AUM
$200M
AUM Growth
+$24M
Cap. Flow
+$15.1M
Cap. Flow %
7.55%
Top 10 Hldgs %
48.67%
Holding
206
New
28
Increased
39
Reduced
30
Closed
7

Top Buys

Rank Stock Value
1
AEM icon
Agnico Eagle Mines
AEM
+$2.71M
2
DVN icon
Devon Energy
DVN
+$1.47M
3
GE icon
GE Aerospace
GE
+$1.44M
4
EMR icon
Emerson Electric
EMR
+$1.16M
5
VZ icon
Verizon
VZ
+$1.14M

Top Sells

Rank Stock Value
1
KVUE icon
Kenvue
KVUE
+$981K
2
RTX icon
RTX Corp
RTX
+$769K
3
PXD
Pioneer Natural Resource Co.
PXD
+$683K
4
NTR icon
Nutrien
NTR
+$292K
5
FNV icon
Franco-Nevada
FNV
+$244K

Sector Composition

Rank Sector Weight
1 Technology 19.62%
2 Energy 13.91%
3 Industrials 13.81%
4 Healthcare 11.36%
5 Communication Services 10.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNY icon
51
Sanofi
SNY
$104B
$772K 0.39%
+15,910
New +$767K
IBB icon
52
iShares Biotechnology ETF
IBB
$9.81B
$770K 0.38%
5,610
-100
-2% -$13.3K
GD icon
53
General Dynamics
GD
$106B
$750K 0.37%
2,585
+360
+16% +$105K
PFE icon
54
Pfizer
PFE
$152B
$732K 0.37%
26,170
-1,630
-6% -$44.9K
B
55
Barrick Mining
B
$67.2B
$707K 0.35%
42,383
+27,282
+181% +$463K
WEC icon
56
WEC Energy
WEC
$34.8B
$680K 0.34%
8,672
TECK icon
57
Teck Resources
TECK
$32.4B
$669K 0.33%
13,975
POR icon
58
Portland General Electric
POR
$5.69B
$669K 0.33%
15,300
EOG icon
59
EOG Resources
EOG
$75.2B
$644K 0.32%
5,115
+2,650
+108% +$340K
MPLX icon
60
MPLX
MPLX
$60.1B
$639K 0.32%
+15,000
New +$618K
NOC icon
61
Northrop Grumman
NOC
$81.8B
$630K 0.31%
1,446
-100
-6% -$45.7K
CCJ icon
62
Cameco
CCJ
$43B
$590K 0.29%
12,000
DIA icon
63
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$48.2B
$588K 0.29%
1,500
FCX icon
64
Freeport-McMoran
FCX
$96.4B
$537K 0.27%
11,050
MAIN icon
65
Main Street Capital
MAIN
$5.52B
$494K 0.25%
9,780
LMT icon
66
Lockheed Martin
LMT
$138B
$494K 0.25%
1,057
CL icon
67
Colgate-Palmolive
CL
$73.6B
$485K 0.24%
+5,000
New +$461K
KVUE icon
68
Kenvue
KVUE
$36.6B
$469K 0.23%
25,810
-50,643
-66% -$981K
ROK icon
69
Rockwell Automation
ROK
$49.6B
$460K 0.23%
1,672
JPM icon
70
JPMorgan Chase
JPM
$962B
$423K 0.21%
2,092
FSM icon
71
Fortuna Silver Mines
FSM
$3.21B
$412K 0.21%
+84,250
New +$425K
PRME icon
72
Prime Medicine
PRME
$591M
$399K 0.2%
77,690
+72,690
+1,454% +$441K
LLY icon
73
Eli Lilly
LLY
$1.08T
$389K 0.19%
430
CTVA icon
74
Corteva
CTVA
$50.9B
$386K 0.19%
7,150
-200
-3% -$11K
BRK.B icon
75
Berkshire Hathaway Class B
BRK.B
$1.11T
$382K 0.19%
939
-10
-1% -$4.09K

Similar funds

Chelsea Counsel Company's Q2 2024 Portfolio in Review

As of Q2 2024, Chelsea Counsel Company held 206 positions worth $200M, up 14% from $176M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Chelsea Counsel Company deployed $15.1M of net new capital in Q2 2024, opening 28 new positions and adding to 39 existing holdings. Its largest new stake was Sanofi: 15,910 shares worth $772K.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Energy and Industrials.

On the sell side, the largest reduction was Kenvue, an estimated $981K trimmed.

  • Chelsea Counsel Company's largest Q2 2024 buy was Sanofi: 15,910 shares worth $772K.
  • Chelsea Counsel Company added most to Agnico Eagle Mines in Q2 2024, an estimated $2.71M increase.
  • Chelsea Counsel Company's biggest Q2 2024 reduction was Kenvue, cutting an estimated $981K.
  • Chelsea Counsel Company fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $683K.
  • Chelsea Counsel Company's ten largest holdings make up 49% of its $200M portfolio in Q2 2024.
  • Chelsea Counsel Company opened 28 new positions and closed 7 in Q2 2024.
  • Chelsea Counsel Company's portfolio value rose 14% quarter-over-quarter to $200M.

Based on Chelsea Counsel Company's 13F filing for Q2 2024, filed 21 Nov 2024.